Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.
Abdou Y, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Unger JM, Tripathy D, Hortobagyi GN, Pusztai L, Kalinsky K.
Abdou Y, et al. Among authors: chia skl.
J Natl Cancer Inst. 2024 Dec 5:djae314. doi: 10.1093/jnci/djae314. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 39656951